Live news related to SARTORIUS STED BIO stock (FR0013154002): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
On Tuesday midday, Sartorius Stedim Biotech recorded a sharp rebound of 6.65%, reaching 170.80 euros, after hitting a level corresponding to its techn…
Sartorius Stedim Biotech gains 3.85% midday this Tuesday, reaching 168.70 euros after closing at 162.45 euros the previous day. This rebound occurs in…
Sartorius Stedim Biotech has fallen by 3.22% midday this Monday, to 159.30 euros, amid a significant downturn in European markets. The stock now shows…
RBC Capital ajuste sa position sur Sartorius Stedim Biotech ce vendredi 6 mars.
Sartorius Stedim Biotech ends the week on a negative note, declining by 2.56% this Friday, March 6, to 165.80 euros. The stock has fallen below a key …
Sartorius Stedim Biotech shares increased by 2.78% this Friday morning, reaching 180.85 euros, after several sessions of gains bringing the weekly per…
Sartorius Stedim Biotech has shown a rebound of 3.06% this Friday, reaching 173.35 euros, after testing a level close to its technical support the pre…
HSBC ajuste sa position sur Sartorius Stedim Biotech ce mercredi 11 février.
Sartorius Stedim Biotech significantly declined this Wednesday, dropping 2.44% to 174.15 euros by midday. The stock has recorded its seventh consecuti…
The Board of Directors of Sartorius Stedim Biotech S.A. has approved a proposed dividend of €0.69 per share for the fiscal year 2025, subject to the a…
